Cargando…
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment
The regulatory role of microRNAs (miRNAs) in HBV-associated HCC pathogenesis has been reported previously. This study aimed to investigate the association between serum miR-125b and liver fibrosis progression in chronic hepatitis B (CHB) patients after nucleos(t)ide analog (NA) treatment. Baseline s...
Autores principales: | Wu, Jyun-Yi, Tsai, Yi-Shan, Li, Chia-Chen, Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsu, Jia-Ning, Hsieh, Meng-Hsuan, Chen, Yo-Chia, Liu, Ta-Wei, Lin, Yi-Hung, Liang, Po-Cheng, Lin, Zu-Yau, Chuang, Wan-Long, Yu, Ming-Lung, Dai, Chia-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687764/ https://www.ncbi.nlm.nih.gov/pubmed/36359344 http://dx.doi.org/10.3390/biomedicines10112824 |
Ejemplares similares
-
High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
por: Lin, Ching-Chung, et al.
Publicado: (2019) -
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
por: Kuwano, Akifumi, et al.
Publicado: (2023) -
Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
por: Lee, I-Cheng, et al.
Publicado: (2015) -
Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2018) -
Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
por: Siakavellas, Spyros, et al.
Publicado: (2021)